-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$991.1319.68% Upside
Recent Analyst Forecasts and Stock Ratings
Regeneron Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. has been rated by research analysts at Evercore ISI, Wells Fargo, Truist Financial, Leerink Partners, Robert W. Baird, Goldman Sachs in the past 90 days.